Lewis R J RJ - OmicsDI

Show results for

Unknown (575)
Genomics (28)
Proteomics (6)
Metabolomics (3)

Organisms

Homo sapiens (28)
Conus caracteristicus (1)
Conus zonatus (1)
Mus musculus (1)

Repository

EGA (28)
MassIVE (4)
MetaboLights (3)
pride (2)

Tissue

Cell suspension culture (1)
Epithelial cell (1)
Fibroblast (1)
Venom gland (1)

Disease

Breast cancer (1)

Technology Type

Illumina 15K (8)
Mass spectrometry (3)
Mass Spectrometry (2)
AB SOLiD 4 System, Illumina HiSeq 2500, Illumina HiSeq 2000, AB SOLiD System 3.0 (1)
Shotgun proteomics (1)
Top-down proteomics (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (3)
LTQ Orbitrap Velos (2)
LTQ Orbitrap (1)
LTQ Orbitrap Elite (1)
Orbitrap Eclipse (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2020 (2)
2022 (1)
2019 (1)
2014 (1)
2024 (1)
2023 (1)
2021 (1)

CHEBI ID

CHEBI:17351 (3)
CHEBI:136085 (2)
CHEBI:15843 (2)
CHEBI:16359 (2)
CHEBI:28792 (2)
CHEBI:30805 (2)
CHEBI:72998 (2)
CHEBI:10023 (1)
CHEBI:10028 (1)
CHEBI:10029 (1)
CHEBI:10037 (1)
CHEBI:10089 (1)
CHEBI:10095 (1)
CHEBI:10106 (1)
CHEBI:10112 (1)
CHEBI:10117 (1)
CHEBI:10119 (1)
CHEBI:10121 (1)
CHEBI:10135 (1)
CHEBI:10137 (1)
CHEBI:1014 (1)
CHEBI:10214 (1)
CHEBI:102216 (1)
CHEBI:102484 (1)
CHEBI:102524 (1)
CHEBI:10276 (1)
CHEBI:10319 (1)
CHEBI:111173 (1)
CHEBI:113 (1)
CHEBI:113543 (1)

Metabolite Name

Linoleic acid (3)
Arachidonic acid (2)
Cholic acid (2)
Lauric acid (2)
PC(16:0/0:0) (2)
PC(18:2/18:2) (2)
(+)-10-deoxymethynolide (1)
(+)-castanospermine (1)
(+)-syringaresinol (1)
(+/-)-abscisic acid (1)
(+/-)-camphor (1)
(+/-)-camphoric acid (1)
(+/-)12(13)-dihome (1)
(+/-)19(20)-dihdpa (1)
(+/-)8(9)-dihet ((8R,9R)-DHET) (1)
(+/-)9(10)-epome (1)
(+/-)9,10-dihydroxy-12z-octadecenoic acid (1)
(+/-)9-hpode (1)
(-)-andrographolide (1)
(10s)-juvenile hormone iii diol (1)
(11s,12e,14z)-11-hydroxy-12,14-icosadienoic acid (1)
(14r)-3beta,5,6beta,10,16-pentahydroxygrayanotoxan-14-yl acetate (1)
(17beta)-4-(acetylsulfanyl)-3-oxoandrost-4-en-17-yl propionate (1)
(1r,2r,6s,7s,8r,10s,11s,12r,16r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-16-isopropenyl-4,18-dimethyl-14-nonyl-9,13,15,19-tetraoxahexacyclo[12.4.1.0~1,11~.0~2,6~.0~8,10~.0~12,16~]nonadec-3-en-5-one (1)
(1s,3z)-4-methylene-3-[(2e)-2-{(1r,3as,7ar)-7a-methyl-1-[(2r)-7,7,7-trifluoro-6-hydroxy-2-heptanyl]octahydro-4h-inden-4-ylidene}ethylidene]cyclohexanol (1)
(20z)-17-oxo-20-hexacosenoic acid (1)
(25s)-5beta-spirostan-3beta-yl beta-d-glucoside (1)
(2e)-3-[4-(sulfooxy)phenyl]acrylic acid (1)
(2e)-4-{3-[2-(2,4-dihydroxyphenyl)-2-oxoethyl]-4,6-dihydroxy-2-methoxyphenyl}-2-methyl-2-buten-1-yl hydrogen sulfate (1)
(2r)-2,3-dihydroxypropanoic acid (1)

Release Date

2021 (71)
2023 (63)
2022 (60)
2020 (51)
2024 (48)
2018 (47)
2025 (40)
2019 (31)
2017 (22)
2015 (21)
2016 (17)
2012 (16)
2014 (15)
2009 (14)
2013 (12)
2010 (10)
2026 (9)
2011 (9)
2008 (9)
2007 (4)
2006 (3)
2005 (2)
2002 (1)

Lab affiliation

Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide SA 5000, Australia (1)
Molecular Biophysics Unit, Indian Institute of Science, Bangalore. (1)

Previous page
1 / 62
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 62
Next page

Sort by:

Relevance

Page size

Identification of regulators of polyploidization presents therapeutic targetsfor treatment of AMKL

Wen Q, Goldenson B, Silver SJ, Schenone M, Dancik V, Huang Z, Wang LZ, Lewis TA, An WF, Li X, Bray MA, Thiollier C, Diebold L, Gilles L, Vokes MS, Moore CB, Bliss-Moreau M, Verplank L, Tolliday NJ, Mishra R, Vemula S, Shi J, Wei L, Kapur R, Lopez CK, Gerby B, Ballerini P, Pflumio F, Gilliland DG, Go...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2014-01-27 | MSV000078536 | MassIVE

Gallium-containing polymer brush film as efficient supported Lewis acid catalyst in a glass microreactor.

Not available

S-EPMC3778416 | biostudies-literature

Coupled Mass-Spectrometry-Based Lipidomics Machine Learning Approach for Early Detection of Clear Cell Renal Cell Carcinoma

A discovery-based lipid profiling study of serum samples from a cohort that included patients with clear cell Renal Cell Carcinoma (ccRCC) stage I, II, III, and IV (n=112) and controls (n=52) was performed using ultraperformance liquid chromatography coupled to quadrupole-time-of-flight mass spec...

2020-11-20 | MTBLS1839 | MetaboLights

Postoperative Metabolic Phenoreversion in Clear Cell Renal Cell Carcinoma

The ultimate goal of surgical treatment in cancer is to remove the tumor mass for restoring a healthy state. A 16-lipid panel that discriminated healthy controls from clear cell renal cell carcinoma (ccRCC) patients in a prior study was evaluated in the present work in paired-serum samples collec...

2023-01-02 | MTBLS3838 | MetaboLights

Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.

Not available

S-EPMC5286943 | biostudies-literature

Interpreting vibrational circular dichroism spectra: the Cai•factor for absolute configuration with confidence.

Not available

S-EPMC10031863 | biostudies-literature

Clinical outcomes with second-line dolutegravir in people with virological failure on first-line non-nucleoside reverse transcriptase inhibitor-based regimens in South Africa: a retrospective cohort study.

Not available

S-EPMC10805003 | biostudies-literature

Advancing Structure Elucidation with a Flexible Multi-Spectral AI Model.

Not available